Concepedia

Renoprotective Effects

Renoprotective Effects is a therapeutic outcome characterized by the preservation or improvement of kidney function, specifically through the attenuation of renal glucose reabsorption and reduction in intraglomerular pressure mediated by Sodium-Glucose Cotransporter 2 Inhibitors.

2.2K

Publications

116.8K

Citations

13.1K

Authors

2.5K

Institutions

Publications per year

2017–2026

902

Parents

Publications

2.2K

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

, , +16

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy

The Lancet · 2000 · 3.2K citations

, , +17

The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

Hendrik Lehnert, Jens Brøchner‐Mortensen, Ramón Gomis et al. · New England Journal of Medicine · 2001 · 2.9K citations

, , +17

[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].

Hans‐Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen et al. · PubMed · 2001 · 2.5K citations

, , +17

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving et al. · Kidney International · 2004 · 970 citations · Full text

, , +14

1–5 of 2.2K

Authors

13.1K

  1. GR
    Giuseppe Remuzzi

    Mario Negri Institute for Pharmacological Research, Italy

    42 publications · 6.1K citations

    35

    h-index

  2. ME
    Mark E. Cooper

    Baker Heart and Diabetes Institute, Australia

    31 publications · 4.4K citations

    27

    h-index

  3. DD
    Dick de Zeeuw

    University of Groningen, Netherlands

    26 publications · 3.2K citations

    21

    h-index

  4. HJ
    Hiddo J.L. Heerspink

    University Medical Center Groningen, Netherlands

    19 publications · 1.9K citations

    19

    h-index

  5. PR
    Peter Rossing

    Steno Diabetes Centers, Denmark

    20 publications · 2.1K citations

    17

    h-index

1–5 of 13.1K

Institutions

2.5K

  1. Mario Negri Institute for Pharmacological Research

    Milan, Italy

    35 h-index

    232 publications

    28K citations

  2. University Medical Center Groningen

    Groningen, The Netherlands

    28 h-index

    168 publications

    19K citations

  3. Steno Diabetes Centers

    Charlottenlund, Denmark

    26 h-index

    92 publications

    14.7K citations

  4. The University of Melbourne

    Melbourne, Australia

    25 h-index

    103 publications

    7K citations

  5. University of Groningen

    Groningen, The Netherlands

    24 h-index

    140 publications

    7.4K citations

  6. Baker Heart and Diabetes Institute

    Melbourne, Australia

    22 h-index

    130 publications

    15.6K citations

  7. Brigham and Women's Hospital

    Boston, United States

    21 h-index

    78 publications

    7.3K citations

  8. Fudan University

    Shanghai, China

    20 h-index

    131 publications

    5.6K citations

1–8 of 2.5K

Venues

  1. Journal of the American Society of Nephrology

    84 publications · 10.1K citations

    61

    h-index

  2. American Journal of Physiology-Renal Physiology

    91 publications · 5.7K citations

    44

    h-index

  3. Kidney International

    50 publications · 5.3K citations

    35

    h-index

  4. PLoS ONE

    60 publications · 3.5K citations

    33

    h-index

  5. Nephrology Dialysis Transplantation

    NDT · 63 publications · 3K citations

    33

    h-index

1–5